On April 1, 2019, the Court of Appeals for the Federal Circuit
(CAFC) issued a decision in Cleveland Clinic Foundation v. True
Health Diagnostics LLC affirming a decision by the U.S District
Court for the Eastern District of Virginia that held claim 1 of
U.S. Patent No. 9,575,065 and claims 1 and 2 of U.S. Patent No.
9,581,597 invalid under 35 U.S.C. §101 for being directed to a
natural law without reciting an inventive concept beyond the
natural law itself.
The Cleveland Clinic Foundation and Cleveland HeartLab, Inc.,
(collectively, "Cleveland Clinic") appealed from a
decision of the United States District Court for the Eastern
District of Virginia, dismissing their complaint for patent
infringement against True Health Diagnostics LLC under Rule
12(b)(6) and holding claim 1 of U.S. Patent 9,575,065 (the
"'065 patent") and claims 1 and 2 of U.S. Patent
9,581,597 (the "'597 patent") invalid under 35 U.S.C.
§ 101 as directed to an ineligible natural law.